No indications that vaccine causes blood clots, EU medicines regulator clarifies

Millions have received the Oxford AstraZeneca jab. But despite successful trials and data showing high levels of effectiveness here in the UK, the vaccine has been dogged by public scepticism in Europe.

Now, another set-back: regulators in Denmark, Norway and Iceland have suspended the jab, after reports of a small number of people suffering blood clots. That’s despite the fact the European Medicines regulator says there is “no indication” the vaccine is linked to an increased risk.